The power of pills social, ethical and legal issues in drug development, marketing, and pricing /
Na minha lista:
Autor Corporativo: | ebrary, Inc |
---|---|
Outros Autores: | Cohen, Jillian Clare, Illingworth, Patricia M. L., 1954-, Schüklenk, Udo |
Formato: | Recurso Electrónico livro electrónico |
Idioma: | inglês |
Publicado em: |
London ; Ann Arbor, Mich. :
Pluto,
2006.
|
Assuntos: | |
Acesso em linha: | An electronic book accessible through the World Wide Web; click to view |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Registos relacionados
How to develop and implement a national drug policy
Publicado em: (2001)
Publicado em: (2001)
Regulating pharmaceuticals in Europe striving for efficiency, equity and quality /
Publicado em: (2004)
Publicado em: (2004)
Coherence for health innovation for new medicines for infectious diseases.
Publicado em: (2009)
Publicado em: (2009)
The risks of prescription drugs
Publicado em: (2010)
Publicado em: (2010)
Effective drug regulation a multicountry study /
Por: Ratanawijitrasin, Sauwakon
Publicado em: (2002)
Por: Ratanawijitrasin, Sauwakon
Publicado em: (2002)
Building a national framework for the establishment of regulatory science for drug development workshop summary /
Publicado em: (2011)
Publicado em: (2011)
Pharmaceutical reform a guide to improving performance and equity /
Por: Roberts, Marc J.
Publicado em: (2011)
Por: Roberts, Marc J.
Publicado em: (2011)
Reputation and power organizational image and pharmaceutical regulation at the FDA
Por: Carpenter, Daniel P., 1967-
Publicado em: (2010)
Por: Carpenter, Daniel P., 1967-
Publicado em: (2010)
Breakthrough business models drug development for rare and neglected diseases and individualized therapies : workshop summary /
Publicado em: (2009)
Publicado em: (2009)
Pharmacy on a bicycle innovative solutions to global health and poverty /
Por: Bing, Eric G.
Publicado em: (2013)
Por: Bing, Eric G.
Publicado em: (2013)
A practical approach to pharmaceutical policy
Por: Seiter, Andreas
Publicado em: (2010)
Por: Seiter, Andreas
Publicado em: (2010)
The future of drug safety promoting and protecting the health of the public /
Publicado em: (2007)
Publicado em: (2007)
Incentives for global public health patent law and access to essential medicines /
Publicado em: (2010)
Publicado em: (2010)
Access to medicines and vaccines in the South : coherence of rules and policies applied by the European Union Commission /
Por: Kingah, Stephen
Publicado em: (2011)
Por: Kingah, Stephen
Publicado em: (2011)
Pharmaceutical pricing policies in a global market
Publicado em: (2008)
Publicado em: (2008)
The $800 million pill the truth behind the cost of new drugs /
Por: Goozner, Merrill, 1950-
Publicado em: (2004)
Por: Goozner, Merrill, 1950-
Publicado em: (2004)
Of medicines and markets intellectual property and human rights in the free trade era /
Por: Godoy, Angelina Snodgrass
Publicado em: (2013)
Por: Godoy, Angelina Snodgrass
Publicado em: (2013)
Towards drugs of the future key issues in lead finding and lead optimization /
Publicado em: (2008)
Publicado em: (2008)
Drugs : from discovery to approval /
Por: Ng, Rick
Publicado em: (2015)
Por: Ng, Rick
Publicado em: (2015)
Les prix des medicaments sur un marche global politiques et enjeux.
Publicado em: (2008)
Publicado em: (2008)
The agile approach to adaptive research optimizing efficiency in clinical development /
Por: Rosenberg, Michael J.
Publicado em: (2010)
Por: Rosenberg, Michael J.
Publicado em: (2010)
ADME-enabling technologies for drug design and development
Publicado em: (2012)
Publicado em: (2012)
Pharmaceutical blending and mixing /
Publicado em: (2015)
Publicado em: (2015)
Happy-people-pills for all
Por: Walker, Mark (Mark Alan)
Publicado em: (2013)
Por: Walker, Mark (Mark Alan)
Publicado em: (2013)
Innovation in the biopharmaceutical industry
Publicado em: (2007)
Publicado em: (2007)
Ghost-Managed Medicine : Big Pharma’s Invisible Hands /
Por: Sismondo, Sergio
Publicado em: (2018)
Por: Sismondo, Sergio
Publicado em: (2018)
Drug discovery practices, processes, and perspectives /
Publicado em: (2013)
Publicado em: (2013)
Negotiating health : intellectual property and access to medicines /
Publicado em: (2006)
Publicado em: (2006)
Pharmaceutical industry innovation and developments /
Publicado em: (2011)
Publicado em: (2011)
Pills, power, and policy the struggle for drug reform in Cold War America and its consequences /
Por: Tobbell, Dominique A., 1978-
Publicado em: (2012)
Por: Tobbell, Dominique A., 1978-
Publicado em: (2012)
Therapeutic targets modulation, inhibition, and activation /
Publicado em: (2012)
Publicado em: (2012)
Manufacturing of pharmaceutical proteins : from technology to economy /
Por: Behme, Stefan
Publicado em: (2015)
Por: Behme, Stefan
Publicado em: (2015)
Drug repositioning bringing new life to shelved assets and existing drugs /
Publicado em: (2012)
Publicado em: (2012)
Outsourcing clinical development strategies for working with CROs and other partners /
Publicado em: (2006)
Publicado em: (2006)
Profits before people? ethical standards and the marketing of prescription drugs /
Por: Weber, Leonard J., 1942-
Publicado em: (2006)
Por: Weber, Leonard J., 1942-
Publicado em: (2006)
Pharmaceutical economics and policy
Por: Schweitzer, Stuart O.
Publicado em: (2007)
Por: Schweitzer, Stuart O.
Publicado em: (2007)
Registos relacionados
-
How to develop and implement a national drug policy
Publicado em: (2001) -
Regulating pharmaceuticals in Europe striving for efficiency, equity and quality /
Publicado em: (2004) -
Coherence for health innovation for new medicines for infectious diseases.
Publicado em: (2009) -
The risks of prescription drugs
Publicado em: (2010) -
Effective drug regulation a multicountry study /
Por: Ratanawijitrasin, Sauwakon
Publicado em: (2002)